The Autoimmune Neuromuscular & Nerve Disorders Drug Development Summit is the first industry-led forum dedicated to transforming the MG, CIDP, GBS and MMN treatment landscapes, bringing together biopharma leaders to tackle the mechanistic and translational challenges shaping this rapidly evolving space.
This meeting is uniquely positioned to address these challenges. Unlike pathway-specific or clinician-led events, it is indication-focused, mechanism-driven and tailored exclusively to drug developers, enabling deeper discussion on pathophysiology, differentiation and translational strategy.
As competition intensifies and more companies enter the space, success will depend on how well you understand, and exploit, the underlying biology. Join your peers to de-risk development, identify new opportunities and gain a competitive edge in one of the fastest-moving areas of immunology and neurology.
Find out more in the Event Guide here: https://autoimmune-neuromuscular-drugdevelopment.com/full-event-guide/
Published on 27 April 2026.
